A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)

PHASE3TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

February 24, 2023

Study Completion Date

February 24, 2023

Conditions
Recurrent C. Difficile Infection
Interventions
BIOLOGICAL

CP101

CP101 is an investigational microbiome therapeutic designed to deliver a complete and functional microbiome to durably repair intestinal dysbiosis, which is being evaluated for the prevention of recurrent Clostridioides difficile infection (CDI).

OTHER

Placebo

Placebo

Trial Locations (68)

10016

NYU Langone Medical Center, New York

10029

Mount Sinai Hospital, New York

10065

Weill Cornell Medicine, New York

10467

Montefiore Medical Center, The Bronx

11030

North Shore University Hospital-(Manhasset), Manhasset

11758

Digiovanna Institute For Medical Education and Research, North Massapequa

13210

Central New York Research Corporation, Syracuse

15801

TruCare Internal Medicine & Infectious Diseases, DuBois

17601

Regional GI, Lancaster

18840

Guthrie Clinic, Sayre

19104

University of Pennsylvania, Philadelphia

19718

Christiana Care Health System, Newark

20052

George Washington University School of Medicine and Health, Washington D.C.

20815

Chevy Chase Clinical Research, Chevy Chase

24501

Infectious Diseases Associates of Central Virginia, Lynchburg

27157

Wake Forest Baptist Medical Center, Winston-Salem

27599

University of North Carolina at Chapel Hill, Chapel Hill

27834

Brody School of Medicine at ECU, Greenville

28374

Pinehurst Medical Clinic Inc, Pinehurst

29414

Lowcountry Infectious Diseases PA, Charleston

29569

Main Street Physicians Care, Loris

30308

Emory University Hospital Midtown, Atlanta

32224

Mayo Clinic Jacksonville, Jacksonville

32256

ENCORE Borland-Groover Clinical Research, Jacksonville

32608

University of Florida Health, Gainesville

33014

San Marcus Research Clinic Inc, Miami

33136

Sylvester Comprehensive Cancer Center, Miami

33165

Reliant Medical Research, Miami

33614

Guardian Angel Research, Tampa

St Joseph's Comprehensive Research Institute, Tampa

33709

Theia Clinical Research, LLC, St. Petersburg

34102

Gastroenterology Group of Naples, Naples

39503

MedPharmics LLC, Gulfport

45219

Gastro Health LLC, Cincinnati

48336

William Beaumont Hospital, Farmington Hills

48377

Henry Ford Health System, Novi

50266

Iowa Clinic, Des Moines

55905

Mayo Clinic, Rochester

59701

Mercury Street Medical Group, Butte

60077

NorthShore University HealthSystem, Evanston

60153

Loyola University Medical Center, Maywood

60527

Metro Infectious Disease Consultants, Burr Ridge

63304

St. Charles Clinical Research, LLC, Weldon Spring

70121

Ochsner Clinic Foundation, New Orleans

75010

Digestive Health Associates of Texas, PA, Carrollton

77025

Kelsey Seybold Clinic, Houston

77090

1960 Family Practice P.A., Houston

78229

Southern Star Research Institute LLC, San Antonio

80045

University of Colorado School of Medicine, Aurora

83404

Snake River Research, PLLC, Idaho Falls

84132

University of Utah, Salt Lake City

85054

Mayo Clinic, Phoenix

91345

Facey Medical Foundation, Mission Hills

94143

UCSF, San Francisco

94305

Stanford Healthcare, Stanford

94611

Kaiser Permanente Division of Research, Oakland

06610

Bridgeport Hospital, Bridgeport

06518

Medical Research Center of Connecticut LLC, Hamden

06106

Hartford Hospital, Hartford

02115

Brigham and Womens Hospital, Boston

02904

Women's Medicine Collaborative, Providence

T2N 4N1

University of Calgary - Calgary Health Region, Calgary

T4P 1K4

CARe Clinic, Red Deer

V7M 1Z8

Yazdan Medical Corporation, Vancouver

V8R 1J8

Vancouver Island Health Authority, Victoria

B3H 4R2

Dalhousie University, Halifax

N6A 4V2

Saint Joseph's Health Care London, London

M5G 1L7

University Health Network, Toronto

All Listed Sponsors
lead

Finch Research and Development LLC.

INDUSTRY